By Business/Source
Currency:EUR
2025/Q3
Stock NameRevenueRatio
Pharmaceuticals4.34B45.12%
Crop Science3.86B40.15%
Consumer Health1.42B14.73%
By Country/Region
Currency:EUR
2024/FY
Stock NameRevenueRatio
United States14.8B31.75%
Europe / Middle East / Africa11B23.59%
Asia / Pacific4.47B9.59%
Brazil4.32B9.26%
Latin America3.76B8.07%
China3.6B7.72%
Germany2.41B5.17%
North America1.68B3.61%
Switzerland575M1.23%
View all